Anticipated Shortage

APO-CEFUROXIME

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-CEFUROXIME in Canada?

A shortage of APO-CEFUROXIME 250MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 24, 2026), but it has not started yet.

Why is APO-CEFUROXIME not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-CEFUROXIME be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusAnticipated Shortage

Same-ingredient products on file6 products

Affected strength250MG

Last updated2026-08-24

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

CEFTIN TAB 250MG

GLAXO CANADA INC

250MG · DIN 00886890

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

CEFTIN FOR ORAL SUSPENSION-PWS 250MG/PCK

GLAXO CANADA INC

250MG · DIN 02145286

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

CEFTIN - PWR 250MG/SACHET

GLAXOSMITHKLINE INC

250MG · DIN 02212293

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

CEFTIN TAB 500MG

GLAXO CANADA INC

500MG · DIN 00886904

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

NOVO-CEFUROXIME

NOVOPHARM LIMITED

500MG · DIN 02230127

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

CEFTIN PWS 125MG/5ML

GLAXO CANADA INC

125MG · DIN 01943049

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02244393

Strength

250MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

CEFUROXIME

See all CEFUROXIME products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-08-24

Anticipated Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244